Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Athenex to Build Two Manufacturing Plants in Chongqing

publication date: Oct 16, 2015
Athenex, a specialty oncology pharmaceutical company in the US previously named Kinex, signed an agreement with the Banan District in Chongqing to construct two separate pharmaceutical manufacturing plants on Banan sites. Banan will provide the funding for the land and construction of the manufacturing plants and Athenex will equip and operate the facilities. In addition, the agreement established a framework for a translational medicine collaboration with an existing Athenex R&D partner, the Polytechnic University of Hong Kong. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital